A carregar...

A dose-finding study of carboplatin–epirubicin–docetaxel in advanced epithelial ovarian cancer

The docetaxel–carboplatin combination is active and well tolerated in patients with epithelial ovarian cancer. We added epirubicin to this combination to investigate additional benefits of anthracyclines in epithelial ovarian cancer. Twenty-one patients, FIGO Ic-IV, performance status 0–1, were trea...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: O'Neill, V J, Kaye, S B, Reed, N S, Paul, J, Davis, J A, Vasey, P A
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group 2002
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2375366/
https://ncbi.nlm.nih.gov/pubmed/11986768
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjc.6600259
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!